(4R,7S,10R,13R)-10-((1H-Indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-13-((R)-2-amino-3-phenylpropanamido)-7-(4-a minobutyl)-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxamide
CAS : 158899-10-6
Ref. 3D-IGA89910
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
(4R,7S,10R,13R)-10-((1H-Indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-13-(2-(2-(2-(2-(2-(2-(2-(2 -(pyridin--4 (1H)
methoxy) phenyl) ethoxy) ethoxy) ethoxy) ethoxy) ethoxy) propanamido)-7-(4-[(dimethylamino)methyl]butyl)-6,9,12--trioxo--1,2--dithia--5,8,11--triazacyclotetrad eca ne -4 carboxamide is a peptide that inhibits the human potassium channel KvAP. It is used as a research tool and has been shown to activate the human calcium channel